Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds and Insiders Love Warner Chilcott Plc (NASDAQ:WCRX)?

Is Warner Chilcott Plc (NASDAQ:WCRX) the right pick for your portfolio? The smart money is selling. The number of long hedge fund positions dropped by 3 in recent months.

Warner Chilcott Plc (NASDAQ:WCRX)

At the moment, there are a multitude of metrics market participants can use to monitor publicly traded companies. A pair of the most innovative are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top hedge fund managers can beat the S&P 500 by a healthy margin (see just how much).

Equally as important, positive insider trading activity is another way to break down the stock market universe. As the old adage goes: there are many incentives for an insider to downsize shares of his or her company, but just one, very obvious reason why they would behave bullishly. Plenty of empirical studies have demonstrated the useful potential of this tactic if you know what to do (learn more here).

Keeping this in mind, it’s important to take a gander at the key action surrounding Warner Chilcott Plc (NASDAQ:WCRX).

Hedge fund activity in Warner Chilcott Plc (NASDAQ:WCRX)

Heading into 2013, a total of 22 of the hedge funds we track were long in this stock, a change of -12% from the third quarter. With hedge funds’ sentiment swirling, there exists an “upper tier” of key hedge fund managers who were increasing their holdings meaningfully.

Of the funds we track, Jacob Gottlieb’s Visium Asset Management had the most valuable position in Warner Chilcott Plc (NASDAQ:WCRX), worth close to $113 million, accounting for 3.9% of its total 13F portfolio. Coming in second is D. E. Shaw of D E Shaw, with a $110 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Other hedge funds that are bullish include Steven Cohen’s SAC Capital Advisors, Samuel Isaly’s OrbiMed Advisors and Gregg J. Powers’s Private Capital Management.

Due to the fact that Warner Chilcott Plc (NASDAQ:WCRX) has faced declining sentiment from hedge fund managers, logic holds that there lies a certain “tier” of hedge funds that elected to cut their positions entirely last quarter. It’s worth mentioning that Cliff Asness’s AQR Capital Management dropped the biggest investment of the “upper crust” of funds we watch, comprising about $45 million in stock.. John Overdeck and David Siegel’s fund, Two Sigma Advisors, also dropped its stock, about $6 million worth. These moves are important to note, as aggregate hedge fund interest fell by 3 funds last quarter.

What have insiders been doing with Warner Chilcott Plc (NASDAQ:WCRX)?

Insider purchases made by high-level executives is most useful when the company in focus has experienced transactions within the past six months. Over the latest 180-day time frame, Warner Chilcott Plc (NASDAQ:WCRX) has seen zero unique insiders purchasing, and 13 insider sales (see the details of insider trades here).

With the results exhibited by our strategies, everyday investors must always pay attention to hedge fund and insider trading sentiment, and Warner Chilcott Plc (NASDAQ:WCRX) is no exception.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!